healthcare.digital August 19, 2024
Lloyd Price

Nelson Advisors Partner and HealthTech M&A Advisor Lloyd Price sharing his thoughts on the Revenue Cycle Management (RCM) market and USD $7Bn bid for R1 RCM with the team at MergerMarket

Revenue cycle management (RCM) has become one of the brightest stars in the healthcare technology firmament after the USD $7Bn bid for R1 RCM [NASDAQ:RCM] from private-equity groups TowerBrook Capital Partners and Clayton, Dubilier & Rice on 1st August.

The attraction is simple: Financial sponsors and strategics continue to see blue sky for growth both organically and through acquisition in a highly fragmented market that quite literally pays the bills in healthcare.

RCM software helps hospitals, doctors and other healthcare groups bill for services and collect payments.

“It’s clearly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Unlocking Hidden Revenue: Transforming RCM Challenges into Financial Wins
Protecting revenue integrity in the age of denials — 4 takeaways
8 Tips for Effective Revenue Cycle Technology Management
Aspirion names CEO
R1 RCM posts $19.9M net loss in Q3

Share This Article